Cargando…

The Role of Capsid in HIV-1 Nuclear Entry

HIV-1 can infect non-dividing cells. The nuclear envelope therefore represents a barrier that HIV-1 must traverse in order to gain access to the host cell chromatin for integration. Hence, nuclear entry is a critical step in the early stages of HIV-1 replication. Following membrane fusion, the viral...

Descripción completa

Detalles Bibliográficos
Autores principales: Guedán, Anabel, Caroe, Eve R., Barr, Genevieve C. R., Bishop, Kate N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402913/
https://www.ncbi.nlm.nih.gov/pubmed/34452291
http://dx.doi.org/10.3390/v13081425
_version_ 1783745905137025024
author Guedán, Anabel
Caroe, Eve R.
Barr, Genevieve C. R.
Bishop, Kate N.
author_facet Guedán, Anabel
Caroe, Eve R.
Barr, Genevieve C. R.
Bishop, Kate N.
author_sort Guedán, Anabel
collection PubMed
description HIV-1 can infect non-dividing cells. The nuclear envelope therefore represents a barrier that HIV-1 must traverse in order to gain access to the host cell chromatin for integration. Hence, nuclear entry is a critical step in the early stages of HIV-1 replication. Following membrane fusion, the viral capsid (CA) lattice, which forms the outer face of the retroviral core, makes numerous interactions with cellular proteins that orchestrate the progress of HIV-1 through the replication cycle. The ability of CA to interact with nuclear pore proteins and other host factors around the nuclear pore determines whether nuclear entry occurs. Uncoating, the process by which the CA lattice opens and/or disassembles, is another critical step that must occur prior to integration. Both early and delayed uncoating have detrimental effects on viral infectivity. How uncoating relates to nuclear entry is currently hotly debated. Recent technological advances have led to intense discussions about the timing, location, and requirements for uncoating and have prompted the field to consider alternative uncoating scenarios that presently focus on uncoating at the nuclear pore and within the nuclear compartment. This review describes recent advances in the study of HIV-1 nuclear entry, outlines the interactions of the retroviral CA protein, and discusses the challenges of investigating HIV-1 uncoating.
format Online
Article
Text
id pubmed-8402913
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84029132021-08-29 The Role of Capsid in HIV-1 Nuclear Entry Guedán, Anabel Caroe, Eve R. Barr, Genevieve C. R. Bishop, Kate N. Viruses Review HIV-1 can infect non-dividing cells. The nuclear envelope therefore represents a barrier that HIV-1 must traverse in order to gain access to the host cell chromatin for integration. Hence, nuclear entry is a critical step in the early stages of HIV-1 replication. Following membrane fusion, the viral capsid (CA) lattice, which forms the outer face of the retroviral core, makes numerous interactions with cellular proteins that orchestrate the progress of HIV-1 through the replication cycle. The ability of CA to interact with nuclear pore proteins and other host factors around the nuclear pore determines whether nuclear entry occurs. Uncoating, the process by which the CA lattice opens and/or disassembles, is another critical step that must occur prior to integration. Both early and delayed uncoating have detrimental effects on viral infectivity. How uncoating relates to nuclear entry is currently hotly debated. Recent technological advances have led to intense discussions about the timing, location, and requirements for uncoating and have prompted the field to consider alternative uncoating scenarios that presently focus on uncoating at the nuclear pore and within the nuclear compartment. This review describes recent advances in the study of HIV-1 nuclear entry, outlines the interactions of the retroviral CA protein, and discusses the challenges of investigating HIV-1 uncoating. MDPI 2021-07-22 /pmc/articles/PMC8402913/ /pubmed/34452291 http://dx.doi.org/10.3390/v13081425 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Guedán, Anabel
Caroe, Eve R.
Barr, Genevieve C. R.
Bishop, Kate N.
The Role of Capsid in HIV-1 Nuclear Entry
title The Role of Capsid in HIV-1 Nuclear Entry
title_full The Role of Capsid in HIV-1 Nuclear Entry
title_fullStr The Role of Capsid in HIV-1 Nuclear Entry
title_full_unstemmed The Role of Capsid in HIV-1 Nuclear Entry
title_short The Role of Capsid in HIV-1 Nuclear Entry
title_sort role of capsid in hiv-1 nuclear entry
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402913/
https://www.ncbi.nlm.nih.gov/pubmed/34452291
http://dx.doi.org/10.3390/v13081425
work_keys_str_mv AT guedananabel theroleofcapsidinhiv1nuclearentry
AT caroeever theroleofcapsidinhiv1nuclearentry
AT barrgenevievecr theroleofcapsidinhiv1nuclearentry
AT bishopkaten theroleofcapsidinhiv1nuclearentry
AT guedananabel roleofcapsidinhiv1nuclearentry
AT caroeever roleofcapsidinhiv1nuclearentry
AT barrgenevievecr roleofcapsidinhiv1nuclearentry
AT bishopkaten roleofcapsidinhiv1nuclearentry